ABIVAX Soci?t? Anonyme - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
ABVX Nasdaq 2836 www.abivax.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for ABIVAX Soci?t? Anonyme

Abivax (ABVX): Cleared Safety Overhang and Phase 3 Data De-Risk Path to Commercialization - Oct 7th, 2026 9:02 am
Abivax to Present Data on Obefazimod at United European Gastroenterology (UEG) Week 2026 - Sep 30th, 2026 2:05 pm
ABIVAX Société Anonyme (ENXTPA:ABVX) Just Gave Investors Something To Think About - Sep 27th, 2026 3:09 am
ABIVAX Société Anonyme (ENXTPA:ABVX) Appoints New Chief Medical And Technical Officers - Sep 26th, 2026 1:08 pm
ABIVAX (ABVX) Uses More Cash. Can its Funding Cover a Potential Launch? - Sep 25th, 2026 10:03 pm
Abivax Presents Business Updates and First Half 2026 Financial Results - Sep 21st, 2026 2:05 pm
4 Biotech Stocks to Watch as Potential Takeover Targets - Sep 18th, 2026 10:31 am
Abivax SA Sponsored ADR (ABVX) Upgraded to Buy: Here's Why - Sep 8th, 2026 10:00 am
Ulcerative Colitis Market Outlook: 5 Late-Stage Drug Candidates to Watch | DelveInsight - Sep 7th, 2026 11:00 am
Evexta Bio Announces Clinical Trial Collaboration and Supply Agreement with Roche to Evaluate Rupitasertib in Combination with a Selective Estrogen Receptor Degrader in Advanced / Metastatic Breast Cancer - Aug 4th, 2026 1:00 am
AbbVie Q2 Earnings Call Highlights - Jul 31st, 2026 9:04 am
Abivax Announces Positive Pre-NDA Interaction with the FDA for Obefazimod - Jul 30th, 2026 2:05 pm
Inflammatory Bowel Disease Market to Experience Strong Uptake During the Forecast Period (2026-2036), Driven by Development of Next-generation Therapies Targeting IL-23, TL1A, and S1P Pathways | DelveInsight - Jul 30th, 2026 8:31 am
PK MED Strengthens Its Strategic and Scientific Governance to Support the Development of Its Therapeutic Micro-implants - Jul 29th, 2026 1:00 am
ABIVAX Société Anonyme (ENXTPA:ABVX) Adds Commercial Leaders, Is The Upside Already Priced In? - Jul 26th, 2026 2:07 am
Abivax (ENXTPA:ABVX) Adds Commercial Leaders And Signs Valerio R And D Deal - Jul 25th, 2026 4:07 am
Abivax Strengthens Commercial Capabilities With Strategic Leadership Appointments - Jul 23rd, 2026 2:05 pm
Valerio Therapeutics Announces Development Collaboration with Abivax and Provides Pipeline Update - Jul 16th, 2026 1:07 am
Abivax: Wall Street Catches Up to the Data - Jul 7th, 2026 10:25 am